Synopsis
Synopsis
0
VMF
0
FDF
0
Canada
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Alcon, Betaxolol
2. Alo 1401 02
3. Alo-1401-02
4. Alo140102
5. Betaxolol
6. Betaxolol Alcon
7. Betoptic
8. Betoptima
9. Hydrochloride, Betaxolol
10. Kerlon
11. Kerlone
12. Oxodal
13. Sl 75212
14. Sl-75212
15. Sl75212
1. 63659-19-8
2. Betaxolol Hcl
3. Betoptic
4. Kerlone
5. Betoptima
6. Lokren
7. Betaxolol (hydrochloride)
8. Alo 1401-02
9. Sl75212
10. Betaxolol Hydrochloride (betoptic)
11. Nsc-760048
12. Alo-1401-02
13. Betoptic S
14. Mls000863279
15. 6x97d2xt0o
16. Dextrobetaxolol (hydrochloride)
17. Kerlon
18. 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol;hydrochloride
19. Alo-140102
20. Smr000058420
21. Sl-7521210
22. Sl 75.212-10
23. Sl-75.212-10
24. 1-(isopropylamino)-3-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)propan-2-ol Hydrochloride
25. Betaxolo Hydrochloride
26. 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-isopropylamino-2-propanol Hydrochloride
27. 2-propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-, Hydrochloride, (+-)-
28. Chebi:643228
29. Chemical Name: 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-isopropylamino-2-propanol Hydrochloride
30. Betaxolol Hydrochloride [usan]
31. Sr-01000000108
32. Einecs 264-384-3
33. Mfcd00242959
34. Sl-75212-10
35. Unii-6x97d2xt0o
36. Kerlong
37. Sl-75212
38. Levobetaxololhcl
39. Sl 75 212-10
40. Betoptic (tn)
41. Prestwick_779
42. Kerlone (tn)
43. Betaxolol Hydrochloride [usan:usp:jan]
44. Cpd000058420
45. Opera_id_878
46. (+-)-1-(p-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-(isopropylamino)-2-propanol Hydrochloride
47. 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-isopropylaminopropan-2-ol Hydrochloride
48. Chembl1691
49. Schembl42794
50. Mls000028464
51. Mls000758269
52. Mls001148209
53. Mls001424199
54. Mls002222261
55. Betaxolol Hydrochloride- Bio-x
56. Sl 75212 Hcl
57. Betaxolol For Peak Identification
58. Hy-b0381a
59. Dtxsid30979876
60. Mci-144
61. Hms1569m05
62. Pharmakon1600-01505512
63. (2s)-1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol;hydrochloride
64. Bcp02967
65. Betaxolol Hydrochloride [mi]
66. Tox21_500193
67. Betaxolol Hydrochloride (jp17/usp)
68. Betaxolol Hydrochloride [jan]
69. Nsc760048
70. Akos015843993
71. Ac-1412
72. Bcp9000394
73. Betaxolol Hydrochloride [mart.]
74. Betaxolol Hydrochloride [vandf]
75. Ccg-101057
76. Ccg-213473
77. Lp00193
78. Nc00307
79. Nsc 760048
80. Betaxolol Hydrochloride [usp-rs]
81. Betaxolol Hydrochloride [who-dd]
82. Betaxolol Hydrochloride, >98% (hplc)
83. Ncgc00093669-01
84. Ncgc00093669-02
85. Ncgc00260878-01
86. As-18082
87. Bb164245
88. Bcp0726000249
89. B4474
90. Betaxolol Hydrochloride [orange Book]
91. Eu-0100193
92. Ft-0645228
93. S1827
94. Sw196917-4
95. Betaxolol Hydrochloride [ep Monograph]
96. B 5683
97. Betaxolol Hydrochloride [usp Monograph]
98. D00598
99. T71164
100. Kerledex Component Betaxolol Hydrochloride
101. 659x198
102. A803574
103. Betaxolol Hydrochloride Component Of Kerledex
104. Q-200714
105. Sr-01000000108-2
106. Sr-01000000108-4
107. Sr-01000000108-9
108. Betoptic Pilo Component Betaxolol Hydrochloride
109. Q27105180
110. Betaxolol Hydrochloride Component Of Betoptic Pilo
111. Betaxolol Hydrochloride, European Pharmacopoeia (ep) Reference Standard
112. Betaxolol Hydrochloride, United States Pharmacopeia (usp) Reference Standard
113. 1-(isopropylamino)-3-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)propan-2-ol Hcl
114. 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol;hydron;chloride
115. 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-isopropylamino-2-propanolhydrochloride
116. Betaxolol For Peak Identification, European Pharmacopoeia (ep) Reference Standard
117. (+/-)-1-(p-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-(isopropylamino)-2-propanol Hydrochloride
118. 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(isopropylamino)propan-2-ol Hydrochloride;levobetaxolol Hydrochloride
119. 2-propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-, Hydrochloride, (+/-)-
120. 72424-72-7
Molecular Weight | 343.9 g/mol |
---|---|
Molecular Formula | C18H30ClNO3 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 11 |
Exact Mass | 343.1914215 g/mol |
Monoisotopic Mass | 343.1914215 g/mol |
Topological Polar Surface Area | 50.7 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 286 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Betaxolol hydrochloride |
PubMed Health | Betaxolol (Into the eye) |
Drug Classes | Antiglaucoma |
Drug Label | Betaxolol Ophthalmic Solution USP, contains betaxolol hydrochloride, a cardioselective beta-adrenergic receptor blocking agent, in a sterile isotonic solution. Betaxolol hydrochloride is a white, crystalline powder, soluble in water, with a molecular... |
Active Ingredient | Betaxolol hydrochloride |
Dosage Form | Solution/drops; Tablet |
Route | Ophthalmic; Oral |
Strength | 10mg; eq 0.5% base; 20mg |
Market Status | Prescription |
Company | Wockhardt; Epic Pharma; Kvk Tech; Bausch And Lomb; Akorn |
2 of 6 | |
---|---|
Drug Name | Betoptic |
PubMed Health | Betaxolol (Into the eye) |
Drug Classes | Antiglaucoma |
Drug Label | BETOPTIC Sterile Ophthalmic Solution contains betaxolol hydrochloride, a cardioselective beta-adrenergic receptor blocking agent, in a sterile isotonic solution. Betaxolol hydrochloride is a white, crystalline powder, soluble in water, with a molec... |
Active Ingredient | Betaxolol hydrochloride |
Dosage Form | Solution/drops |
Route | Ophthalmic |
Strength | eq 0.5% base |
Market Status | Prescription |
Company | Alcon |
3 of 6 | |
---|---|
Drug Name | Betoptic s |
Active Ingredient | Betaxolol hydrochloride |
Dosage Form | Suspension/drops |
Route | Ophthalmic |
Strength | eq 0.25% base |
Market Status | Prescription |
Company | Alcon |
4 of 6 | |
---|---|
Drug Name | Betaxolol hydrochloride |
PubMed Health | Betaxolol (Into the eye) |
Drug Classes | Antiglaucoma |
Drug Label | Betaxolol Ophthalmic Solution USP, contains betaxolol hydrochloride, a cardioselective beta-adrenergic receptor blocking agent, in a sterile isotonic solution. Betaxolol hydrochloride is a white, crystalline powder, soluble in water, with a molecular... |
Active Ingredient | Betaxolol hydrochloride |
Dosage Form | Solution/drops; Tablet |
Route | Ophthalmic; Oral |
Strength | 10mg; eq 0.5% base; 20mg |
Market Status | Prescription |
Company | Wockhardt; Epic Pharma; Kvk Tech; Bausch And Lomb; Akorn |
5 of 6 | |
---|---|
Drug Name | Betoptic |
PubMed Health | Betaxolol (Into the eye) |
Drug Classes | Antiglaucoma |
Drug Label | BETOPTIC Sterile Ophthalmic Solution contains betaxolol hydrochloride, a cardioselective beta-adrenergic receptor blocking agent, in a sterile isotonic solution. Betaxolol hydrochloride is a white, crystalline powder, soluble in water, with a molec... |
Active Ingredient | Betaxolol hydrochloride |
Dosage Form | Solution/drops |
Route | Ophthalmic |
Strength | eq 0.5% base |
Market Status | Prescription |
Company | Alcon |
6 of 6 | |
---|---|
Drug Name | Betoptic s |
Active Ingredient | Betaxolol hydrochloride |
Dosage Form | Suspension/drops |
Route | Ophthalmic |
Strength | eq 0.25% base |
Market Status | Prescription |
Company | Alcon |
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Adrenergic beta-1 Receptor Antagonists
Drugs that bind to and block the activation of ADRENERGIC BETA-1 RECEPTORS. (See all compounds classified as Adrenergic beta-1 Receptor Antagonists.)
Sympatholytics
Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12638
Submission : 1997-08-29
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25301
Submission : 2011-09-22
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10727
Submission : 1994-02-04
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17235
Submission : 2004-02-16
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12680
Submission : 1997-10-02
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8662
Submission : 1990-07-19
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5464
Submission : 1984-07-19
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3800
Submission : 1980-05-09
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7615
Submission : 1988-07-29
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Dosage Form : Tablet
Grade : Not Available
Application : Co-Processed Excipients
Excipient Details : Direct Compression
Dosage Form : Tablet
Grade : Not Available
Application : Co-Processed Excipients
Excipient Details : Standard Direct Tabletting Or Roller Compaction
Dosage Form : Tablet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Film Forming Agent, Wet/Dry Granulation- Binder,Thickening & Suspension Agent, Non-Gelatin Capsule Manufacturing & Enteric Film Coating Systems
Pharmacopoeia Ref : USP, EP, and JP
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methylcellulose
Dosage Form : Tablet
Grade : Not Available
Application : Controlled & Modified Release
Excipient Details : Sustained Release Tablet Matrix
Pharmacopoeia Ref : USP, EP, and JP
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methylcellulose
Dosage Form : Tablet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Immediate Release
Pharmacopoeia Ref : Customized per requirements
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methylcellulose
Dosage Form : Tablet
Grade : Not Available
Application : Controlled & Modified Release
Excipient Details : Immediate Release
Pharmacopoeia Ref : Customized per requirements
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methylcellulose
Dosage Form : Tablet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Immediate Release
Pharmacopoeia Ref : Customized per requirements
Technical Specs : Not Available
Ingredient(s) : Polydextrose Sugar
Dosage Form : Tablet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Enteric Coatings
Pharmacopoeia Ref : Customized per requirements
Technical Specs : Not Available
Ingredient(s) : EthylCellulose
Dosage Form : Tablet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Immediate Release
Pharmacopoeia Ref : Customized per requirements
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methylcellulose
Dosage Form : Tablet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Immediate Release
Pharmacopoeia Ref : Customized per requirements
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methylcellulose
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?